Medicine
Abilify Maintena kit
Abilify Maintena kit is a prescription medicine containing Aripiprazole, marketed by Otsuka America Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store below 30°C [86°F]. Vial: Store at 25°C (77°F), excursions…
Key facts
- Active ingredient (INN)
- Aripiprazole
- Brand
- Abilify Maintena
- Dosage form
- Kit
- Packs
- 1 kit and 1 more
- Marketing authorisation holder
- Otsuka America Pharmaceutical
- Manufacturer
- Otsuka America Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store below 30°C [86°F]. Vial: Store at 25°C (77°F), excursions permitted between 15°C and 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AX12 Aripiprazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 October 2014
- Identifiers
- RxCUI 1602163, 1602171, 1602604 +5DailyMed set ID ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6NDC 59148-045, 59148-072, 59148-232 +1Application NDA202971
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 1.5 mL in 1 syringe * 5 mL in 1 syringe | 59148-045-80 | Otsuka America Pharmaceutical | 8 October 2014 |
| 1 kit in 1 carton * 1.9 mL in 1 syringe * 5 mL in 1 syringe | 59148-072-80 | Otsuka America Pharmaceutical | 8 October 2014 |
| 1 kit in 1 carton * 1.5 mL in 1 vial, single-use * 2.5 mL in 1 vial, single-use | 59148-232-12 | Otsuka America Pharmaceutical | 28 February 2025 |
| 1 kit in 1 carton * 1.9 mL in 1 vial, single-use * 2.5 mL in 1 vial, single-use | 59148-245-12 | Otsuka America Pharmaceutical | 28 February 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Aripiprazole
Clinical summary
Aripiprazole is an atypical antipsychotic. It is available as tablets, orally disintegrating tablets and oral solution for intramuscular use. MedsAcross supplies Aripiprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AripiprazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ABILIFY prescribing information (Otsuka America Pharmaceutical) · U.S. National Library of Medicine, DailyMed
- Abilify Maintena: European public assessment report (EPAR) · European Medicines Agency
- Abilify: European public assessment report (EPAR) · European Medicines Agency
Need Abilify Maintena kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.